The first study of COVID-19 vaccine effectiveness in a large population of adult heart-failure patients suggests that vaccinated participants are 82% more likely to live longer than their unvaccinated peers, according to an analysis presented over the weekend at the Heart Failure 2024 scientific congress of the European Society of Cardiology (ESC) in Lisbon, Portugal.
More than 64 million global heart-failure patients
Researchers from the National Health Insurance Service Ilsan Hospital in Goyang, South Korea, analyzed information on vaccinations and clinical outcomes among 147,118 heart-failure patients from the Korean National Health Insurance Service database, which covers nearly all Koreans.